Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul-Sep;44(3):457-461.
doi: 10.1590/2175-8239-JBN-2020-0254.

Presumed cytomegalovirus retinitis late after kidney transplant

[Article in English, Portuguese]
Affiliations
Case Reports

Presumed cytomegalovirus retinitis late after kidney transplant

[Article in English, Portuguese]
Filipa Silva et al. J Bras Nefrol. 2022 Jul-Sep.

Abstract

Cytomegalovirus (CMV) retinitis is a rare manifestation of CMV invasive disease and potentially threatening to vision in immunocompromised individuals. Clinical suspicion is fundamental since it is an unusual entity with a progressive and often asymptomatic installation over a long period. The authors report a 70-year-old man with diabetic nephropathy who underwent a kidney transplant (KT) in August 2014 with good clinical evolution. No previous CMV infection or episodes of acute rejection were reported. Five years after transplant, he was admitted due to a reduced visual acuity of the left eye with seven days of evolution with associated hyperemia, without exudate. The ophthalmologic evaluation was compatible with acute necrosis of the retina and presumed associated with CMV infection. He had a progressive improvement after ganciclovir initiation. CMV retinitis is one of the most serious ocular complications in immune-suppressed individuals and can lead to irreversible blindness, and because of that, early diagnosis and treatment remains crucial in obtaining the best visual prognosis in affected patients. Secondary prophylaxis with ganciclovir is not consensual, neither is the safety of reintroducing the antimetabolite in these cases.

A retinite por citomegalovírus (CMV) é uma manifestação rara de doença invasiva por CMV e potencialmente ameaçadora para a visão em indivíduos imunocomprometidos. A suspeita clínica é fundamental, uma vez que se trata de uma entidade incomum, com uma instalação progressiva e frequentemente assintomática durante um longo período. Os autores relatam um homem de 70 anos de idade com doença renal do diabetes que foi submetido a um transplante renal (KT) em Agosto de 2014 com boa evolução clínica. Nenhuma infecção anterior por CMV ou episódios de rejeição aguda foram relatados. Cinco anos após o transplante, ele foi internado devido a uma acuidade visual reduzida do olho esquerdo com sete dias de evolução com hiperemia associada, sem exsudato. A avaliação oftalmológica foi compatível com a necrose aguda da retina e presumivelmente associada à infecção por CMV. Ele teve uma melhora progressiva após o início do ganciclovir. A retinite por CMV é uma das complicações oculares mais graves em indivíduos imunossuprimidos e pode levar à cegueira irreversível e, por isso, o diagnóstico e o tratamento precoces continuam sendo cruciais para obter o melhor prognóstico visual em pacientes afetados. A profilaxia secundária com ganciclovir não é consensual, tampouco a segurança de reintroduzir o antimetabólito nestes casos.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1. Retinography and angiofluoresceinography performed after several days of treatment with ganciclovir. A - Retinography of the left eye with evidence of intra-retinal hemorrhage (arrowhead). B - Peripheral injury at the level of the nasal retina corresponding to a scar from a previous injury. C - Angiofluoresceinography of the entire fundus. Presence of lesions of diabetic retinopathy and possible retinitis scar at the level of the nasal retina (arrowhead).

References

    1. Kotton CN, Kumar D, Caliendo AM. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. Transplantation. 2018;102(6):900–931. doi: 10.1097/TP.0000000000002191. - DOI - PubMed
    1. Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9) doi: 10.1111/ctr.13512. - DOI - PubMed
    1. Khan SF, Yong MK, Slavin MA, Hughes P, Sasadeusz J. Very late-onset cytomegalovirus disease with ganciclovir resistance >15 years following renal transplantation. Transpl Infect Dis. 2020 Aug 16; - PubMed
    1. Eid AJ, Bakri SJ, Kijpittayarit S, Razonable RR. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transplant Infect Dis. 2008;10(1):13–18. doi: 10.1111/j.1399-3062.2007.00241.x. - DOI - PubMed
    1. Crippa F, Corey L, Chuang EL, Sale G, Boeckh M. Virological, Clinical, and Ophthalmologic Features of Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation. Clinical Infectious Diseases. 2001;32(2):214–219. doi: 10.1086/318447. - DOI - PubMed

Publication types

MeSH terms